Suboptimal MMR Vaccination Coverages—A Constant Challenge for Measles Elimination in Romania

Author:

Stanescu Aurora12,Ruta Simona Maria13ORCID,Cernescu Costin4,Pistol Adriana12

Affiliation:

1. Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania

2. National Institute of Public Health, National Centre for Communicable Diseases Surveillance and Control, 050463 Bucharest, Romania

3. Department of Viral Emerging Diseases, Stefan. S. Nicolau Institute of Virology, 030304 Bucharest, Romania

4. Romanian Academy, 010071 Bucharest, Romania

Abstract

Measles is targeted for elimination since 2001, with a significant reduction in cases recorded worldwide, but outbreaks occur periodically due to immunization gaps. This study analyzes the evolution of vaccination coverage rates (VCRs) in Romania, a EU country with large measles epidemics during the last two decades, including an ongoing outbreak in 2023. Vaccination against measles has been part of the National Immunization Program since 1979, initially as a single dose, and from 1994 onwards it has had two doses. The initially high national VCRs of >97% gradually declined from 2010 onward and remained constantly under 90%, with further decreases during the COVID-19 pandemic. The lowest VCRs for both vaccine doses in the last decade were recorded in 2022 and were 83.4% for the first dose and 71.4% for the second dose, with significant differences among Romania’s 42 counties. Several factors contributed to this decline, including failure to attend the general practitioners’ offices, increased number of children lost to follow-up due to population movements, missed vaccination opportunities due to temporary medical contraindications, a surge in vaccine hesitancy/refusal, a decreasing number of general practitioners and discontinuities in vaccine supply. The persisting suboptimal VCRs in Romania threaten the progress toward measles elimination.

Publisher

MDPI AG

Reference38 articles.

1. The basic reproduction number (R0) of measles: A systematic review;Guerra;Lancet Infect. Dis.,2017

2. (2021). European Immunization Agenda 2030, WHO Regional Office for Europe.

3. Funk, S., Knapp, J.K., Lebo, E., Reef, S.E., Dabbagh, A.J., Kretsinger, K., Jit, M., Edmunds, W.J., and Strebel, P.M. (2019). Combining serological and contact data to derive target immunity levels for achieving and maintaining measles elimination. BMC Med., 17.

4. World Health Organization (2020). Measles and Rubella Strategic Framework 2021–2030, World Health Organization. Available online: https://iris.who.int/bitstream/handle/10665/339801/9789240015616-eng.pdf?sequence=1.

5. World Health Organization (2023, October 08). WHO-UNICEF Estimates of MCV1 Coverage. Available online: https://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragemcv1.html.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3